• Explore /
  • Poster
  • / Residual rectal cancer after preoperative radiochemotherapy (ypT1-2): An indication for local excision instead of radical surgery?

Residual rectal cancer after preoperative radiochemotherapy (ypT1-2): An indication for local excision instead of radical surgery?

Abstract Poster

Authors

null

Thilo Sprenger

Department of General, Visceral and Pediatric Surgery, University Medical Center, Georg-August-University, Göttingen, Germany

Thilo Sprenger , Hilka Rothe , Lena-Christin Conradi , Kia Homayounfar , Tim Beissbarth , B. Michael Ghadimi , Torsten Liersch

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon and Rectum

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 546)

DOI

10.1200/jco.2014.32.3_suppl.546

Abstract #

546

Poster Bd #

C51

Abstract Disclosures

Similar Posters

First Author: Kimberly Perez

Poster

2013 Gastrointestinal Cancers Symposium

Neoadjuvant capecitabine and oxaliplatin (XELOX) with bevacizumab for locally advanced rectal cancer.

Neoadjuvant capecitabine and oxaliplatin (XELOX) with bevacizumab for locally advanced rectal cancer.

First Author: Junichi Hasegawa

First Author: Amitesh Chandra Roy

First Author: Yana Qi